NCT05042765View on ClinicalTrials.gov

Entheogen Resurgence

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions
Psychedelic Experiences
Interventions
OTHER

self-reported entheogen use

self-reported participation in therapy or a retreat in a naturalistic setting that incorporated the use of entheogens in the past five (5) years

Trial Locations (1)

11373

Vireo Health of New York, Queens

All Listed Sponsors
lead

Vireo Health

OTHER

NCT05042765 - Entheogen Resurgence | Biotech Hunter | Biotech Hunter